The Vorp Lab has a likely opening for a PhD student! Contact me if any questions!

Really proud of my PhD student Isabelle for taking first prize in her pitch at the PDMA competition last night for our project #EndoDx! We will soon make a difference for women suffering from #endometriosis !! timechg

Please share! We have a #postdoctoral position available immediately in Vorp Lab at the University of Pittsburgh. In brief this is to work on a new NIH U01 project in regen med & tissue eng approaches using #extracellularvesicles in vascular grafting and wound healing. More in🧵:

Endometriosis affects approximately 11% of women in the U.S., yet it is severely understudied. Enter, the Hub for Endometriosis Research, a first-of-its-kind research collaboration by Magee-Womens & Swanson School of Engineering. What is HER? Find out: bit.ly/48sBsqu

Check out the cover story for the current #Magee Magazine! #Endometriosis is such a tragically understudied and #underfunded condition that impacts so many women around the world. Magee-Womens Research Institute & Foundation UPMC University of Pittsburgh PittResearch Pitt Bioengineering

#ICYMI 2023 Virginia Kaufman PAIN Challenge Awardee, Dr. David Vorp and his team were featured in the most recent issue of MAGEE Magazine for their latest project, the Hub for Endometriosis Research (HER). Read below ⬇️

I’m thrilled that Vascular Specialist Online is highlighting our ongoing work through Aneurisk Inc.. Predicting aortic aneurysm growth and rupture is challenging but the clear next step in improving our understanding and treatment timechg David Vorp vascularspecialistonline.com/university-of-…

Some good news for the x-verse! Our publication in scientific reports has been published exploring image-based metrics and patient outcomes using AI techniques: tinyurl.com/4czjj3w8 David Vorp Nathan Liang MD MS Pete Gueldner Vorp Lab

rdcu.be/dyhqc Excited to have this published in Nature's Scientific Reports! We use machine learning methods to predict future outcomes for patients with abdominal aortic aneurysms based on data collected on them today. #AAA #AI #MachineLearning

WATCH: Bioengineering's David Vorp was inspired by his wife and his PhD student to create the multidisciplinary Hub for #Endometriosis Research (HER) to tackle research and advocacy for this incredibly common yet severely understudied disease: news.engineering.pitt.edu/endometriosis-…

Congratulations to Ande Marini, Ph.D. for winning runner up at University of Pittsburgh’s Three Minute Thesis Contest!

Congratulations to all the winners of the MS-level Student Paper Competition at #SB3C2024!

Our team had a great visit today with our collaborators CMU College of Engineering and RoosterBio. Great to see their lab space and see all of the progress we’ve made together!

Great science from Vorp Lab Pitt Bioengineering presented at #ISACB24 ISACB! Sex-differences in AAA 👏🏻👏🏻

Great talks by @KatKerr6 and Ande Marini, Ph.D. from Pitt Bioengineering at ISACB ‘s 19th biennial meeting in Vienna! #womeninstem

Great talk this morning by David Vorp at CMU’s BME seminar!

Fun being the CMU_BME seminar speaker today. We’re next door neighbors/collaborators but don’t always take the time to slow down and really visit with each other. Today we did. Thanks to Vorp Lab for surprising me with your presence as I presented your amazing collective work.

🎉🎉🎉 Congratulations to Doctor Ande Marini! Ande Marini, Ph.D. Vorp Lab Hello Kitty-Roc was a perfect reference 👍. I know you're bound for success and I feel privileged to have had you with the group since 2019.

A huge congrats to DR. Ande Marini Ande Marini, Ph.D. on a successful and wonderful PhD thesis defense. It has been a pleasure to watch her grow. Ande’s leadership and collaborative nature will be sorely missed in the Vorp Lab and I know she will do well as a post-doc at Stanford University.

Congrats to VBL Postdoc, Dr. Kiran McLoughlin on winning Best Poster at the University of Pittsburgh 2025 Postdoctoral Research Symposium! His presentation was titled “EV’s and silk fibroin can deliver and enhance the therapeutic efficiency of multiple cell populations”